TMT. S. Mongush

T. S. Mongush

*This is an algorithmically generated author record based on publicly available information.

T. S. Mongush has a total of 13 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Association of MIR146A (rs2910164) and MIR499A (rs3746444) gene polymorphisms with markers of thromboinflammation in patients with coronary heart disease after coronary artery bypass grafting

    by A. A. Kosinova, K. S. Semashchenko, T. N. Subbotina, Yu. I. Grinshtein, T. S. Mongush, D. Yu. Makarova, A. A. Shalyova

    Background . Advances in genomics and proteomics have facilitated the identification of numerous new candidate biomarkers for the diagnosis and prognosis of coronary heart disease (CHD), as well as for predicting adverse cardiovascular events, including post-coronary artery bypass grafting (CABG) outcomes. MicroRNAs represent a promising category of these biomarkers. Aim : To investigate the association between the rs2910164 polymorphism in the MIR146A gene and the rs3746444 polymorphism in the MIR499A gene with adverse cardiovascular events and general inflammation markers in CHD patients post-CABG. Material and Methods . This prospective cohort study involved 158 CHD patients with a median age of 63 years [58; 67]. Patients were assessed at three stages: preoperatively, on postoperative days 8–10, and post-discharge. Early in-hospital cardiovascular events were recorded over 8–10 days of hospitalization, and long-term events were tracked for an average of 36.1 ± 10.6 months post-CABG. Comprehensive blood analyses and leukocyte DNA genotyping were conducted preoperatively and on days 8–10 postsurgery. Additionally, flow cytometry and high-sensitivity C-reactive protein (CRP) measurement were performed on a random subset of 102 patients. Results . The allele frequencies of G and C (rs2910164) were 0.62 and 0.38, respectively, and those of A and G (rs3746444) were 0.83 and 0.17 in the CHD cohort. No significant differences in rare allele prevalence were observed between patients with and without long-term adverse cardiovascular events. Preoperatively, CHD patients with the GG genotype of rs2910164 MIR146A displayed higher plateletplatelet aggregate counts. Post-CABG, this genotype group showed significantly elevated values in platelet-platelet aggregate mean fluorescence intensity (MFI) (33.1 [31.5; 35.75] vs. 30.0 [29.0; 33.13], p = 0.001), MFI of P-selectin-expressing platelets (4.69 [2.05; 6.77] vs. 1.97 [1.49; 2.53], p = 0.002), MFI of P-selectin-expressing platelet–monocyte (6.71 [4.18; 16.4] vs. 4.22 [3.73; 6.14], p = 0.018), and MFI of P-selectin-expressing platelet-platelet aggregates (5.17 [2.47; 7.24] vs. 2.56 [1.7; 2.94], p = 0.003). The erythrocyte sedimentation rate (ESR) was significantly higher in patients with the C allele preoperatively (60.0 [31.0; 89.0] mm/hr vs. 40.0 [27.75; 57.75] mm/hr, p = 0.043). Conclusions . The presence of rare alleles in rs2910164 ( MIR146A ) and rs3746444 ( MIR499A ) was not associated with an increased frequency of in-hospital or long-term adverse cardiovascular events. However, CHD patients with the GG genotype of rs2910164 MIR146A post-CABG exhibited significantly higher MFI in platelet aggregates expressing P-selectin.

  • Role of intercellular aggregates and oxidative stress markers in assessment of cardiovascular outcomes in patients after coronary artery bypass grafting

    by A. A. Kosinova, Yu. I. Grinshtein, A. N. Maltseva, M. D. Goncharov, T. S. Mongush, A. A. Savchenko

    Aim: To compare the levels of C-reactive protein (CRP), circulating cell aggregates (including P-selectin-expressing aggregates), lipid profiles, and platelet chemiluminescence activity in patients with and without adverse cardiovascular events following coronary artery bypass grafting (CABG). Material and Methods . The study enrolled 102 patients with angina pectoris (functional class II–IV) who underwent CABG. Prior to CABG, comprehensive blood analysis and lipid profile assessment were performed. Both preand postoperatively, platelet chemiluminescence and flow cytometry analyses were conducted. Composite endpoints (worsening angina class, progression of heart failure, myocardial infarction, stroke, cardiovascular death, or repeat revascularization) were evaluated during hospitalization (8–10 days post-CABG) and at 23.3 ± 7.6 months postoperatively. Results . Composite endpoints occurred in 16 patients. Significant differences were observed between groups (no events vs. adverse outcomes). Pre-CABG: monocyte-platelet aggregates: 13.4% [5.9; 24.2] vs. 34.9% [19.05; 50.25], p = 0.001; Mean fluorescence intensity (MFI) of P-selectin-expressing neutrophil-platelet aggregates: 4.85 AU [2.99; 8.79] vs. 12.5 AU [5.09; 15.3], p = 0.005; MFI of P-selectin-expressing monocyte-platelet aggregates: 4.27 AU [2.6; 7.76] vs. 9.53 AU [6.68; 14.8], p = 0.006. Post-CABG: P-selectin-expressing neutrophil-platelet aggregates: 75.7% [62.36; 90.54] vs. 92.3% [80; 99.29], p = 0.027. The median time to peak lucigenin-enhanced platelet chemiluminescence pre-CABG was significantly shorter in patients with adverse events compared to event-free patients (212 s [53; 621] vs. 885 s [257.75; 2087], p = 0.032). Similarly, the median time to peak spontaneous neutrophil chemiluminescence with lucigenin was reduced in the adverse events group (847 s [565; 1018] vs. 1355 s [1065.5; 1898.5], p = 0.017). Conclusion . Patients with composite adverse cardiovascular events exhibited significantly different MFI and platelet-leukocyte aggregate counts (preand post-CABG), pre-operative platelet/neutrophil chemiluminescence peak times, and cardiopulmonary bypass durations compared to event-free patients. These parameters may serve as predictive biomarkers for post-CABG cardiovascular risk and warrant further investigation.

  • Open Access

    Study the Association of Nucleotide Polymorphisms in Platelet Receptor and Cytochrome P450 Genes with the Development of Resistance to Antiplatelet Drugs in Patients with Coronary Artery Disease

    by K. S. Semashchenko, T. S. Mongush, A. A. Kosinova, T. N. Subbotina, Y. I. Grinshtein

    Aim. To study the association of nucleotide polymorphisms in platelet receptor and cytochrome P450 genes with the development of resistance to antiplatelet drugs in CHD patients.Material and Methods. The study included 243 patients diagnosed with CHD after coronary artery bypass surgery (CABG), including 140 patients in the acetylsalicylic acid (ASA) treatment group and 103 patients in the dual antiplatelet therapy (DAT) group. All patients were tested for platelet aggregation using an optical aggregometer with inducers: 5 mM ADP and 1 mM arachidonic acid (AA). DNA samples were analyzed by allele-specific PCR for the presence of polymorphisms rs2046934, rs1126643, rs5918, rs6065, rs4244285 in the platelet receptor and cytochrome P450 genes.Results. No statistically significant differences were found during comparison of the prevalence of the studied polymorphisms in the platelet receptor and cytochrome P450 genes between the groups of aspirin-sensitive and aspirin-resistant patients, as well as between the groups of clopidogrelsensitive and clopidogrel-resistant patients. No association between carriage of the minor and major alleles of the polymorphisms studied and the development of antiplatelet drug resistance was found. In the group of patients on ASA therapy, carriers of the C allele of the T1565C (rs5918) ITGB3 polymorphism had a higher rate of AA-induced platelet aggregation compared to carriers of the T allele (18,49±25,92 vs 10,43±17,34, р=0,004).Conclusion. Polymorphisms of P2RY12 (rs2046934), ITGA2 (rs1126643), ITGB3 (rs5918), GP1BA (rs6065), CYP2C19*2 (rs4244285) genes are not associated with antiplatelet drug resistance in both patients on ASC therapy and on DAT. The presence of minor alleles of the rs2046934, rs1126643, rs6065, rs4244285 polymorphisms are not associated with increased platelet aggregation activity before CABG.However, in the group of patients on ASA therapy C-allele carriers of the rs5918 polymorphism of the ITGB3 gene had a higher rate of AA-induced platelet aggregation compared to T-allele carriers.


  • Open Access

    Aspirin Resistance as a Result of Impaired Interaction of Platelets and Neutrophils in Patients with Coronary Heart Disease

    by M. D. Goncharov, A. A. Savchenko, Yu. I. Grinshtein, I. I. Gvozdev, A. A. Kosinova, T. S. Mongush

    Aim. To study the relationship between the levels of synthesis of reactive oxygen species (ROS) by platelets and neutrophils in patients with coronary heart disease (CHD) before and after coronary artery bypass grafting (CABG), depending on sensitivity to acetylsalicylic acid (ASA).Material and methods. The study included 95 patients with coronary artery disease who are indicated for CABG surgery. The control group consisted of 30 healthy donors. The antiplatelet therapy was stopped for at least 5 days before CABG. In the postoperative period, from the first day, all patients were received 100 mg of an enteric form of acetylsalicylic acid (ASA). Resistance to ASA was determined at the level of platelet aggregation with arachidonic acid ≥20% by optical agregometry at least at one observation point: before CABG, on 1-3 day and on 8-10 day after surgery. We evaluated the spontaneous and induced lucigenin-dependent chemiluminescence (CL) of platelets (ADP induction) and neutrophils (zymosan induction) by the exit time to maximum intensity (Tmax), maximum intensity (Imax) and area (S) under the CL curve.Results. 70.5% sensitive (sASA) and 29.5% resistant (rASA) to ASA patients were revealed. Prior to CABG, in sASA patients, the Imax of spontaneous and zymosan-induced neutrophil CL and CL platelet activity was increased relative to control values. Tmax of spontaneous platelet CL, Imax and S under the ADP-induced platelet CL curve were lower in sASA patients, if to compare with rASA patients. On the 1st and 8-10th day after CABG in sASA patients, the CL indicators of neutrophil and platelet activity also remained elevated compared to control values. On the 1st day after CABG decreased levels of S under the spontaneous CL curve of neutrophils in rASA patients was established compared with sASA patients, and increased levels of Imax and S under the curve of induced neutrophil CL were detected in comparison with the control range. In rASA patients, the values of Tmax of spontaneous platelet CL decreased in relation to the values detected in the control group and sASA patients. On the 8–10th day after CABG, most indicators of spontaneous and zymosan-induced CL neutrophils in rASA patients were also increased compared to control values. In rASA patients a positive correlation of Imax-induced CL was found (r=0.83) on the 1st day after CABG and negative correlations of Tmax of spontaneous CL (r=- 0.75) and S under the curve induced CL (r=-0.70) on the 8-10th day were detected between platelets and neutrophils.Conclusion. In sASA patients with coronary heart disease before and after CABG, a high level of synthesis of superoxide radical by neutrophils and platelets was detected. The relationship between the levels of the synthesis of superoxide radical by neutrophils and platelets was found only after CABG in rASA patients. Increased synthesis of superoxide radical due to metabolic and regulatory relationships in neutrophils and platelets stimulates pro-inflammatory processes in coronary artery disease and determines the sensitivity of platelets to ASA.


  • Open Access

    Association of T715P (RS6136), M62I (RS2228315), S290N (RS6131), V640L (RS6133) polymorphisms in the P-selectin gene and its ligand with acetylsalicylic acid resistance in patients with coronary artery disease after coronary artery bypass grafting

    by A. A. Kosinova, T. S. Mongush, M. D. Goncharov, T. N. Subbotina, K. S. Semashchenko, G. Yu. Kochmareva, Yu. I. Grinshtein, Ю. И. Гринштейн

    Aim.To study the association of T715P (rs6136), M62I (rs2228315), S290N (rs6131), V640L (rs6133) polymorphisms in the P-selectin gene with resistance to acetylsalicylic acid (ASA) in patients with coronary artery disease after coronary artery bypass grafting (CABG).Material and methods. The study included 90 patients aged 61,5±6,9 years (70 men and 20 women) with II-IV functional class (FC) angina pectoris, according to the Canadian Cardiovascular Society grading. The atherosclerotic nature of coronary artery disease is confirmed by coronary angiography. Patients stopped taking antiplatelet agents before CABG for at least 5 days. The aggregation study was carried out with an optical aggregometer using ADP inducers (5 pM) and arachidonic acid (1 µМ) before CABG, on 1-3 and 8-10 days after surgical treatment.DNA samples were examined for the presence of T715P (rs6136), M62I (rs2228315), S290N (rs6131), V640L (rs6133) polymorphisms in the P-selectin gene using realtime PCR with allele-specific primers.Results.When comparing aPTT, fibrinogen level, platelet aggregation activity with ADP inducers (5 µМ) and arachidonic acid (1 µМ), no differences were found among groups of patients with homozygous and heterozygous variants of the studied polymorphisms genotypes, both before and on 1-3, 8 -10 days after CABG. Regarding presence of ASA resistance, patient groups with homozygous variants of genotypes (T715P (rs6136), M62I (rs2228315), S290N (rs6131), V640L (rs6133)) did not statistically differ in prevailing or rare alleles from the corresponding groups with heterozygous genotypes. In the first 10 days of the postoperative period, thrombotic events (4,4%) were observed in 4 patients in the study group: acute myocardial infarction, acute cerebrovascular accident. Regarding frequency of adverse events in the first 10 days after CABG, between groups of patients with homozygous variants of the studied genotypes (T715P (rs6136), M62I (rs2228315), S290N (rs6131), V640L (rs6133) in prevailing allele and groups with heterozygous variants of the corresponding genotypes there were also no statistically significant differences.Conclusion.Rs6133, rs6163, rs2228315, rs6131 polymorphisms in the platelet P-selectin gene are not associated with ASA resistance and are not associated with increased platelet aggregation activity in patients with coronary artery disease. The rare T, C, G, A alleles of the studied polymorphisms do not lead to an increase in the risks of adverse events in the first 10 days after CABG.